EUVIMEDEUVIMED entdecken
Crossref

In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate

Febri Odel Nitbani, Theodore Yehezkiel Kristoferson Lulan, Mayavira Veronica Hahuly, Jefri Semuel Balle, Philiphi De Rozari, Putra Jiwamurwa Pama Tjitda

ACTA Pharmaceutica Sciencia · 2026 · 64 (3) · 481

DOI: 10.23893/1307-2080.aps64025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2026. Verfasst von Febri Odel Nitbani und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nitbani, F. O., Lulan, T. Y. K., Hahuly, M. V., Balle, J. S., Rozari, P. D., & Tjitda, P. J. P. (2026). In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate. ACTA Pharmaceutica Sciencia, 64(3), 481. https://doi.org/10.23893/1307-2080.aps64025

Vancouver

Nitbani FO, Lulan TYK, Hahuly MV, Balle JS, Rozari PD, Tjitda PJP. In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate. ACTA Pharmaceutica Sciencia. 2026;64(3):481. doi:10.23893/1307-2080.aps64025

BibTeX
@article{Nitbani2026,
  author = {Nitbani, Febri Odel and Lulan, Theodore Yehezkiel Kristoferson and Hahuly, Mayavira Veronica and Balle, Jefri Semuel and Rozari, Philiphi De and Tjitda, Putra Jiwamurwa Pama},
  title = {In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate},
  journal = {ACTA Pharmaceutica Sciencia},
  year = {2026},
  volume = {64},
  number = {3},
  pages = {481},
  doi = {10.23893/1307-2080.aps64025}
}
Kostenlos starten →